Completed PHASE1 INTERVENTIONAL 1-arm NCT03495934

A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body

An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Pracinostat in Healthy Male Subjects

Sponsor: Helsinn Healthcare SA

Conditions Healthy Subjects

Interventions pracinostat

Updated 7 times since 2018 Last updated: Aug 7, 2019 Started: Feb 8, 2018 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy Subjects, this trial is completed. The trial is conducted by Helsinn Healthcare SA and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2019 — Jan 2021 [monthly]

Completed PHASE1

Status: Enrolling By Invitation → Completed
Sep 2018 — Sep 2019 [monthly]

Enrolling By Invitation PHASE1

▶ Show 2 earlier versions

Jun 2018 — Sep 2018 [monthly]

Enrolling By Invitation PHASE1
May 2018 — Jun 2018 [monthly]

Enrolling By Invitation PHASE1

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helsinn Healthcare SA
Quotient Sciences

Data source: Helsinn Healthcare SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ruddington, United Kingdom